Atlas Trials

Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)

Clinical trial NCT01724112 · COMPLETED

Trial details

NCT number
NCT01724112
Sponsor
BlackThorn Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2012-11-01
Primary completion
2014-03-01
Enrollment
136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.